Cormark Has Bearish Forecast for Cresco Labs FY2025 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBF) – Research analysts at Cormark dropped their FY2025 earnings estimates for shares of Cresco Labs in a report issued on Monday, November 10th. Cormark analyst J. Pytlak now anticipates that the company will post earnings per share of ($0.16) for the year, down from their prior forecast of ($0.14). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share.

Separately, Zacks Research cut Cresco Labs from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 14th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce”.

Cresco Labs Price Performance

CRLBF stock opened at $1.16 on Wednesday. Cresco Labs has a 52-week low of $0.43 and a 52-week high of $1.62. The company has a quick ratio of 2.22, a current ratio of 2.49 and a debt-to-equity ratio of 1.28. The stock has a market cap of $412.88 million, a price-to-earnings ratio of -7.73 and a beta of 1.51. The business has a fifty day moving average of $1.20 and a two-hundred day moving average of $0.90.

Cresco Labs (OTCMKTS:CRLBF) last released its quarterly earnings data on Friday, November 7th. The company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.02). The business had revenue of $165.00 million during the quarter, compared to analyst estimates of $163.74 million. Cresco Labs had a negative net margin of 7.79% and a negative return on equity of 14.25%.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.